Company Filing History:
Years Active: 2020
Title: Wei-Dong Jiang: Innovator in Anti-Epidermal Growth Factor Receptor Antibodies
Introduction
Wei-Dong Jiang is a notable inventor based in San Jose, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of anti-epidermal growth factor receptor (EGFR) antibodies. His work has implications for therapeutic applications in treating various diseases.
Latest Patents
Wei-Dong Jiang holds a patent for anti-epidermal growth factor receptor (EGFR) antibodies. This patent includes aglycosylated CDR-H2 anti-EGFR antibodies and antigen binding fragments thereof. Additionally, it provides isolated nucleic acid molecules that encode these antibodies or their fragments, related expression vectors, and host cells. The patent also outlines methods for producing these antibodies and their pharmaceutical compositions, which can be used to treat subjects.
Career Highlights
Throughout his career, Wei-Dong Jiang has worked with prominent companies in the biotechnology sector. He has been associated with Henlix Biotech Co., Ltd. and Shanghai Henlius Biotech Inc. His expertise in the field has allowed him to contribute to innovative solutions in medical treatments.
Collaborations
Wei-Dong Jiang has collaborated with Pei-Hua Lin, further enhancing his research and development efforts in the biotechnology industry.
Conclusion
Wei-Dong Jiang's contributions to the development of anti-EGFR antibodies highlight his role as an innovator in biotechnology. His work continues to influence therapeutic strategies in medicine.